In a research report published today, Brean Capital analyst Jonathan Aschoff reaffirmed a Sell rating on Rockwell Medical (NASDAQ:RMTI) with a $4.00 price target, which represents …
In a research report published today to investors, Brean Capital analyst Jonathan Aschoff maintained a Buy rating on Merrimack Pharmaceuticals (NASDAQ:MACK) with a $16 …
In a research report released today to investors, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Tekmira Pharma (NASDAQ:TKMR) and raised his …
In a research report issued today, Roth Capital analyst Debjit Chattopadhyay maintained a Buy rating on Alcobra (NASDAQ:ADHD) with a $40 price target. The report comes …
In a research report released today, Alpha BioPharma’s Paul Nunzio DeSantis initiated coverage on shares of Achillion Pharmaceuticals (NASDAQ:ACHN) with a Buy rating and $16 price …
In a research note published today, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Keryx Biopharmaceuticals (NASDAQ:KERX) with a $26 price target, as the …
In a research report issued today, Roth Capital analyst Philip Shen maintained a Neutral rating on Real Goods Solar (NASDAQ:RGSE) with a price …
In a research note published today, Deutsche Bank analyst Robyn Karnauskas reaffirmed a Buy rating on Gilead Sciences (NASDAQ:GILD) with a $142 price target, …
In a research report released today to investors, H.C.
In a research note released today to investors, H.C.
